High IL-6 concentration at baseline was present in 91 (25%) participants and was associated with 3-fold higher odds of any subsequent unfavorable treatment outcome (95%CI 2.03-5.89, p<0.001) after adjusting for age, sex, BMI, CXR score including cavitation, smear grade, pre-treatment illness duration, HIV, diabetes and correlations within each contributing study (Table-4). Here, IL6 is linked to diabetes mellitus.